| Optum, Inc. | |
|---|---|
Optum headquarters in 2015 | |
| Type | Subsidiary |
| Industry | Healthcare |
| Founded | 2011 |
| Headquarters | , U.S. |
| Key people |
|
| Services | Pharmacy benefit manager, Healthcare provider |
| Revenue | US$270.6 billion (2025) |
| Parent | UnitedHealth Group |
| Subsidiaries | OptumInsight OptumRx OptumHealth Optum Financial |
| Website | optum |
Optum, Inc. is an American healthcare company that provides technology services, pharmacy-care services (including a pharmacy benefit manager) and various direct healthcare services, headquartered in Eden Prairie, Minnesota, United States.
Optum was formed as a subsidiary of UnitedHealth Group in 2011 by merging UnitedHealth's existing pharmacy and care delivery services into the single Optum brand, comprising three main businesses: OptumHealth, OptumInsight and OptumRx.
From the late 2010s through the early 2020s, Optum expanded significantly through a series of mergers and acquisitions. In 2017, the company accounted for 44 percent of UnitedHealth Group's profits. In 2019, Optum's revenues surpassed $100 billion for the first time, growing by 11.1 percent year over year, making it UnitedHealth's fastest-growing unit at the time.
Optum's three businesses, OptumRx, OptumHealth and OptumInsight focus on five core capabilities: data and analytics, pharmacy care services, population health, healthcare delivery and healthcare operations. Optum serves employers, government agencies, health plans, life science companies, care providers and individuals and families, offering products in data and analytics, pharmacy care services, healthcare operations and delivery, population health management and advisory services. The Optum Serve division provides health-related services to U.S. government agencies. In January 2013, Optum, in partnership with the Mayo Clinic, unveiled Optum Labs, a health-data initiative. In October 2013, Optum, in partnership with Dignity Health, launched Optum 360, a revenue-cycle management venture.
Since Optum's founding in 2011, the company has acquired various healthcare technology services to build out its pharmacy-benefit manager and care services offerings.
This Optum-UnitedHealth model of vertical integration is pointed to as having sparked a pattern of acquisition activity in the healthcare industry; most notably, mega-mergers between CVS-Aetna, Cigna-Express Scripts and Humana-Kindred.
"Vertical integration" has met with considerable pushback and claims of antitrust law violations. The Federal Trade Commission (FTC) has accused major pharmacy benefit managers (PBMs), including CVS Caremark and OptumRx, of engaging in anticompetitive practices that harm competition and raise drug prices, citing conflicts of interest and exclusivity provisions.
Similarly, the American Medical Association (AMA) has criticized the CVS-Aetna merger, arguing it undermines competition in pharmacy benefit management services, health insurance, and retail pharmacy markets, leading to higher consumer costs and fewer choices. Ana Gupte, managing director of healthcare services at Leerink, said Optum's approach to acquisitions inspired the Aetna-CVS deal in an interview with Healthcare Dive.
ScriptSwitch Ltd, a software provider acquired by UnitedHealth UK for a reported £50m in 2009, was branded as "ScriptSwitch, provided by Optum" as of 2026.
In early 2019, UnitedHealth Group filed a lawsuit asking a U.S. district judge to stop former Optum executive, David William Smith, from working at Haven (the Amazon, JP Morgan and Berkshire-Hathaway joint-healthcare venture). Optum argued that Haven is in direct competition with its business and as such, Smith's employment would be in violation of a noncompete agreement that he signed while with Optum. Smith, meanwhile, asked the judge to send the parties into closed-door arbitration. Wolf rejected Optum's request and allowed Smith's, putting court proceedings on hold until the arbitration process is complete.
The case garnered media attention as setting a precedent in trade secret litigation ahead of an anticipated wave of vertical integration in the healthcare industry and for uncovering previously unknown details about Haven. The case has also been referred to as having shed light on the threat that pharmacy benefit managers feel to bottom lines amid mounting bipartisan pressure to control rising healthcare costs. Testimony brought by Haven chief operating officer Jack Stoddard was unsealed after a motion brought by the parent companies of Stat News and The Wall Street Journal.
A 2019 study published in Science, alleges the "algorithm used to manage the healthcare of millions of Americans shows dramatic biases against black patients". Said algorithm, applied to over 200 million individuals yearly, "significantly underestimates the amount of care black patients need compared with white patients". In fact, "less money is spent on black patients with the same level of need as white patients, causing the algorithm to conclude that black patients were less sick". Optum claims "its system helps 'clinicians provide more effective patient care every day'".
Optum offers a range of Medicine related products/services, including ScriptSwitch